Thirty years experience in biology. Lipscomb Distinguished Professor of Agriculture at Arkansas State University. Previously, Associate Vice Chancellor for Research and Technology Transfer at ASU. Program Director in Molecular and Cellular Biosciences at the National Science Foundation. Leader in forming one of the world's foremost transgenic plant research groups at ProdiGene, a plant biotechnology start-up company. Director of the cell biology group for plant production of therapeutic proteins at Pioneer Hi-Bred International, a Fortune 500 Company. Internationally recognized for research program and associated expertise as evidenced by over 75 publications and patents as well as invitations to speak nationally and internationally.

Biofuels & Biobased Products, Feedstock Processing, Bioinformatics, Plant Genetics/Breeding, Plant Cell Walls, Plant Made Industrial/Pharmaceutical Proteins, Plant Tissue Culture

M. A. Martin-Luengo graduated in Chemistry (UAM, Spain). In CSIC (Spain), she presented her Master work and her phD on supported catalysts, both with the highest qualification. As a Postdoctoral Grant Holder of the CSIC she worked in UK and Belgium. Afterwards she was granted a Fellowship IA to work with the SERC (UK) on Fischer Tropsch Processes. In 1992 she gained a permanent position of Research Scientist in the CSIC (Spain), where she has been working since. She has more than 100 publications, 120 congresses and several patents, an is member of the RSC, ACS and SECAT.

Nowadays she carries out studies in the search for more sustainable materials and chemical processes based on the valorisation of agriresidues, particularly important in less developed countries. This work has been acknowledged by the CSIC recently.

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors, graduated from Astrakhan State Medical University and awarded with MD, then in 1985 maintained his PhD at the I.M. Sechenov Moscow Medical Academy and in 2001, maintained his Doctorship Degree at the Nat Inst of Immunology, Russia. From 1987 through 1989, he was a senior Researcher, Koltzov Inst of Developmental Biology. From 1989 through 1995, he was a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI. Dr Suchkov has been trained at: NIH; Wills Eye Hospital, PA, USA; Univ of Florida in Gainesville; UCSF, S-F, CA, USA; Johns Hopkins University, Baltimore, MD, USA. He was an Exe Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov Director, Center for Personalized Medicine and Professor, Department of Pathology, Sechenov Univer-sity, Chair, Department for Translational Medicine, Moscow Engineering Physical Institute (MEPhI),Professor, Dept for Immunology, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia Member, New York Academy of Sciences, NY, USA Secretary General, UCC (United Cultural Convention), Cambridge, UK Member, EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brus-sels, EU; Member, ISPM (International Society for Personalized Medicine), Tokyo, Japan; Member, PMC (Personalized Medicine Coalition), Washington, USA; Member, American Chemical Society (ACS), USA; Member, American Heart Association (AHA), USA; Secretary General, UCC (United Cultural Convention), Cambridge, UK.

Medical Sciences

Joy Manglani is an Environment Scientist & Inventor. He holds the prestigious B. Tech. degree from the premier IIT Delhi in Chemical Engineering. He is a founder (since 1983) and President of NGO - Only Nature Endures (ONE) also called One Nature where he trains interns and seniors. He invents and promotes Sustainable Technologies for Joyful Life and Healthy Environment. Has experience of successfully inventing and applying technologies in the fields of Water and Sanitation, Eco-friendly Handcrafted Textiles & Clothing, Organic Farming, Eco-friendly Asbestos Cement, Business revival, Thermal Engineering, Awareness and Justice. His breakthrough invention above can help in solving the Water and Sanitation problem. He was an Advisor to Government of Maharashtra (India) on Water and Sanitation Technologies. He was also an Advisor to Government of India for Safe Industrial Technology. His ancestors and current family are social workers.

Water and Sanitation, Eco-friendly Handcrafted Textiles & Clothing, Organic Farming, Eco-friendly Asbestos Cement, Business revival, Thermal Engineering.

Vladimir P. Torchilin is a University Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. He graduated from the Moscow University with MS in Chemistry, and obtained there his Ph.D. and D.Sc. in Polymer Chemistry and Chemistry of Physiologically Active Compounds in 1971 and 1980, respectively. In 1991, Dr. Torchilin joined MGH/Harvard Medical School as the Head of Chemistry Program, Center for Imaging and Pharmaceutical Research, and Associate Professor of Radiology. Since 1998 Dr. Torchilin is with Northeastern University. He was the Chair of the Department of Pharmaceutical Sciences in 1998-2008. His research interests include drug delivery and targeting, pharmaceutical nanocarriers. He has published more than 350 original papers, more than 150 reviews and book chapters, wrote and edited 10 books, including Immobilized Enzymes in Medicine, Targeted Delivery of Imaging Agents, Liposomes, Nanoparticulates as Pharmaceutical Carriers, and holds more than 40 patents. He is Editor-in-Chief of Current Drug Discovery Technologies and of Drug Delivery and on the Editorial Boards of many journals, including Journal of Controlled Release (Review Editor), Bioconjugate Chemistry and Advanced Drug Delivery Reviews. Among many awards, Professor Torchilin was the recipient of the 1982 Lenin Prize in Science (the highest award in the USSR). He is a Member of European Academy of Sciences. He is also a Fellow of AIMBE, AAPS, and CRS, and received the 2005 Research Achievements in Pharmaceutics and Drug Delivery Award from the AAPS, 2007 Research Achievements Award from the Pharmaceutical Sciences World Congress, 2009 AAPS Journal Award, 2009 International Journal of Nanomedicine Distinguished Scientist Award, 2010 CRS Founders Award, and 2012 Alec Bangham Award. In 2005-2006 he was a President of the Controlled Release Society. In 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2001-2010.

Pharmaceutical Biotechnology

Nikolai Zhelev a Molecular Cell Biologist and Professor of Medical Biotechnology. He also an Honorary Professor in eight universities in the UK, China, Bulgaria and Russia. His laboratory - which conducts research in drug development, cancer and cardiovascular systems biology and nanobiotechnology – has developed the first live-cell biosensor for monitoring activity on cancer targets in tumours. He has developed tiny human hearts - just 1 mm in diameter - which beat of their own accord. His TEDx Talk - How to break a thousand hearts - gives an insight into this research. He is also working with biopharmaceutical and biotech companies on the development of new drugs against cancer and cardiac hypertrophy. He have published three books, five book chapters and more than 90 research papers and patents in the field of DNA damage response, cell cycle regulation and drug discovery and development in oncology and cardiology. He is currently the President of the International BioDiscovery Federation and the Managing Editor of BioDiscovery – the first open access international scientific journal in the field of Life Sciences and Medicine in Scotland.

Molecular Cell Biologist and Medical Biotechnology